KENNETH HYMAN: Open Payments
NPI 1104942762 · LOMPOC, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 9 payments from 8 companies in 2025. Trend: 2023 $186 · 2024 $318 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Zimmer Biomet Holdings, Inc. | 1 | $131 |
| Amgen Inc. | 2 | $42 |
| PFIZER INC. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Aesculap, Inc. | 1 | $19 |
| Bioventus LLC | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Persona, EVENITY, PREVNAR 20, GARDASIL 9, AESCULAP, EXOGEN ULTRASOUND BONE HEALING SYSTEM, Exparel, Wegovy.
Industry payments across CA — which companies pay providers there.
